Genovese; Pietro

Patent Applications and Registrations

Patent applications and USPTO patent grants for Genovese; Pietro.The latest application filed is for "selection by means of artificial transactivators".

Company Profile

3.7.10

Genovese; Pietro - Milan IT
Genovese; Pietro - Messina N/A IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases Grant 11,439,666 - Bonini , et al. September 13, 2	2022-09-13
Selection By Means Of Artificial Transactivators App 20220056484 - Genovese; Pietro ; et al.	2022-02-24
Gene Therapy App 20210260216 - Genovese; Pietro ; et al.	2021-08-26
Gene Therapy App 20210121579 - KAJASTE-RUDNITSKI; Anna Christina ; et al.	2021-04-29
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases Grant 10,918,668 - Gregory , et al. February 16, 2	2021-02-16
Systems And Methods For Treating Hyper-igm Syndrome App 20200338213 - COTTA-RAMUSINO; Cecillia ; et al.	2020-10-29
Targeted Disruption Of T Cell Receptor Genes Using Engineered Zinc Finger Protein Nucleases App 20190046579 - Bonini; Maria Chiara ; et al.	2019-02-14
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases Grant 10,155,011 - Bonini , et al. Dec	2018-12-18
Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells Grant 10,117,899 - Genovese , et al. November 6, 2	2018-11-06
Targeted Disruption Of T Cell Receptor Genes Using Engineered Zinc Finger Protein Nucleases App 20180214485 - Gregory; Philip D. ; et al.	2018-08-02
Targeted disruption of T cell receptor genes using talens Grant 9,937,207 - Gregory , et al. April 10, 2	2018-04-10
Delivery Methods And Compositions For Nuclease-mediated Genome Engineering In Hematopoietic Stem Cells App 20150174169 - Genovese; Pietro ; et al.	2015-06-25
Targeted Disruption Of T Cell Receptor Genes Using Engineered Zinc Finger Protein Nucleases App 20150164954 - Bonini; Maria Chiara ; et al.	2015-06-18
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases Grant 8,956,828 - Bonini , et al. February 17, 2	2015-02-17
Targeted Disruption Of T Cell Receptor Genes Using Engineered Zinc Finger Protein Nucleases App 20140301990 - Gregory; Philip D. ; et al.	2014-10-09
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases App 20110158957 - Bonini; Maria Chiara ; et al.	2011-06-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.